• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

#unfair_hiring_practices

  1. an Embarrassing Start to Future of Working

    in USDS, the new Future of Working guidelines were just released...as expected, EY, AP and one other person can WFH...since there's no logic/transparency as to who can/can't WFH, this is blatant favoritism at its finest. a juicy tidbit on AP: a few weeks ago, she was on a Meet with camera off...